Stock Analysis on Net
Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Common-Size Balance Sheet: Assets
Quarterly Data

Allergan Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011 Dec 31, 2010 Sep 30, 2010 Jun 30, 2010 Mar 31, 2010
Cash and equivalents 39.56 33.58 29.02 26.26 28.81 26.48 25.67 23.77 29.43 29.79 27.31 26.39 28.28 27.03 23.56 30.23 23.97 30.48 28.50 26.08
Short-term investments 0.44 2.36 4.78 7.48 5.70 5.17 1.91 0.54 2.84 3.14 3.51 4.03 2.11 0.81 3.80 2.98 9.02 5.85 0.00 0.00
Trade receivables, net 7.37 8.31 9.60 9.24 8.35 8.95 9.48 9.60 8.33 9.79 10.01 9.85 8.59 8.69 9.44 8.02 7.79 6.87 7.72 7.32
Inventories 2.38 2.56 2.73 2.77 2.70 2.76 2.84 2.91 3.08 2.98 2.99 3.02 2.93 2.96 3.08 2.86 2.76 2.57 2.59 2.88
Other current assets 5.59 5.61 5.74 5.12 4.66 4.34 4.84 5.50 4.89 5.20 5.29 5.52 5.66 5.51 5.71 4.70 4.53 3.91 4.26 4.93
Assets of discontinued operations 0.00 0.00 0.01 0.05 0.09 0.92 1.59 1.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current assets 55.34% 52.41% 51.89% 50.92% 50.31% 48.62% 46.33% 43.99% 48.57% 50.90% 49.11% 48.81% 47.58% 45.00% 45.59% 48.79% 48.07% 49.69% 43.07% 41.22%
Investments and other assets 2.19 2.03 2.17 2.11 2.02 1.89 2.01 2.09 2.09 2.15 2.77 2.85 2.90 3.26 3.32 3.09 3.15 3.38 3.51 3.52
Deferred tax assets 0.70 0.51 1.11 1.13 1.22 1.18 0.92 0.81 2.25 2.11 1.84 1.72 1.79 1.85 3.16 2.90 2.62 1.84 0.22 0.09
Property, plant and equipment, net 8.11 8.63 8.90 8.79 8.73 8.64 8.95 9.23 9.29 9.23 9.36 9.29 9.48 9.67 10.09 9.42 9.64 9.11 10.09 10.43
Goodwill 19.27 20.73 21.30 21.82 22.12 23.01 24.05 25.01 24.40 23.49 24.11 24.15 24.54 25.58 26.03 24.43 24.54 23.93 25.64 26.33
Intangibles, net 14.39 15.68 14.64 15.23 15.60 16.65 17.75 18.87 13.39 12.11 12.81 13.18 13.69 14.65 11.81 11.37 11.99 12.05 17.47 18.42
Non-current assets 44.66% 47.59% 48.11% 49.08% 49.69% 51.38% 53.67% 56.01% 51.43% 49.10% 50.89% 51.19% 52.42% 55.00% 54.41% 51.21% 51.93% 50.31% 56.93% 58.78%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan Inc. current assets as a percentage of total assets increased from Q2 2014 to Q3 2014 and from Q3 2014 to Q4 2014.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Allergan Inc. property, plant and equipment, net as a percentage of total assets decreased from Q2 2014 to Q3 2014 and from Q3 2014 to Q4 2014.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Allergan Inc. non-current assets as a percentage of total assets decreased from Q2 2014 to Q3 2014 and from Q3 2014 to Q4 2014.